L. Markiewicz et E. Gurpide, ESTROGENIC AND PROGESTAGENIC ACTIVITIES OF PHYSIOLOGICAL AND SYNTHETIC ANDROGENS, AS MEASURED BY IN-VITRO BIOASSAYS, Methods and findings in experimental and clinical pharmacology, 19(4), 1997, pp. 215-222
Estrogenic activities of testosterone (T) and 5 alpha-dihydrotestoster
one (DHT) were detected and measured by using their specific stimulato
ry effects on alkaline phosphatase (AP) activity in human endometrial
adenocarcinoma cells of the Ishikawa Var-1 line. These two physiologic
androgens were able to induce, at mu M concentrations, estrogenic eff
ect believed to be mediated by the estrogen receptor (ER) since the an
tiestrogens ICI-164384 and 4-hydroxytamoxifen (OHTam), but not the ant
iandrogens hydroxyflutamide (OHFl) or cyproterone acetate (CPA), rever
sed that effect. By using another in vitro bioassay, based on the prog
estin-specific stimulation of AP activity in cells of the T47D human b
reast cancer line, progestagenic activity was detected and measured in
T, DHT and three synthetic androgens: nandrolone (19-nortestosterone)
, 7 alpha-methyl 19-nortestosterone (MENT) and mibolerone (7 alpha,17
alpha-dimethyl 19-nortestosterone)(DMNT). While progestagenic effects
of T and DHT required relatively high concentrations (mu M levels), th
e synthetic androgens stimulated AP activity at nM or pM levels. These
effects seem to be mediated by the progesterone receptor (PR), since
they are completely abolished by the antiprogestins RU-486, ZK-98299 a
nd ZK-112993, but not by the antiandrogen OHFl. These simple in vitro
bioassays, expressing biological effects of the test compounds in huma
n cells in culture, revealed dual or multiple hormonal activities coex
isting in a single compound and provide quantitative information of co
nsiderable pharmacological importance concerning the complex actions o
f drugs.